Letter ISI SCOPUS
Circulation  (2009)

Response to Letter Regarding Article, "Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel: Thrombolysis in Myocardial Infarction 38"

Wiviott, SD; Braunwald, E; Murphy, SA; McCabe, CH; Antman, EM; Angiolillo, DJ; Meisel, S; Dalby, AJ; Verheugt, FWA; Goodman, SG; Corbalan, R; Purdy, DA

Más información

Título según WOS: Response to Letter Regarding Article, "Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel: Thrombolysis in Myocardial Infarction 38"
Título según SCOPUS: Response to letter regarding article, "greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel: Thrombolysis in myocardial infarction 38"
Título de la Revista: Circulation
Volumen: 119
Número: 25
Editorial: Lippincott Williams and Wilkins
Fecha de publicación: 2009
URL: http://www.scopus.com/inward/record.url?eid=2-s2.0-67650786491&partnerID=q2rCbXpz
DOI:

10.1161/CIRCULATIONAHA.108.844050
Notas: ISI, SCOPUS